Literature DB >> 20521072

S100A2 in cancerogenesis: a friend or a foe?

Susann Wolf1, Cathleen Haase-Kohn, Jens Pietzsch.   

Abstract

Owing to the exceptional intracellular distribution and the heterogeneous expression pattern during transformation and metastasis in various tumors, the EF-hand calcium-binding protein S100A2 attracts increasing attention. Unlike the majority of S100 proteins, S100A2 expression is downregulated in many cancers and the loss in nuclear expression has been associated with poor prognosis. On the other hand, S100A2 is upregulated in some cancers. This mini review highlights the general characteristics of S100A2 and discusses recent findings on its putative functional implication as a suppressor or promoter in cancerogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20521072     DOI: 10.1007/s00726-010-0623-2

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  22 in total

1.  Multiple S100 protein isoforms and C-terminal phosphorylation contribute to the paralog-selective regulation of nonmuscle myosin 2 filaments.

Authors:  Péter Ecsédi; Neil Billington; Gyula Pálfy; Gergő Gógl; Bence Kiss; Éva Bulyáki; Andrea Bodor; James R Sellers; László Nyitray
Journal:  J Biol Chem       Date:  2018-08-07       Impact factor: 5.157

2.  Differential effects of S100 proteins A2 and A6 on cardiac Ca(2+) cycling and contractile performance.

Authors:  Wang Wang; Michelle L Asp; Guadalupe Guerrero-Serna; Joseph M Metzger
Journal:  J Mol Cell Cardiol       Date:  2014-03-11       Impact factor: 5.000

3.  Clinical significance of S100A2 expression in gastric cancer.

Authors:  Ying-Fu Liu; Qing-Qing Liu; Xuan Wang; Chun-Hua Luo
Journal:  Tumour Biol       Date:  2013-12-07

4.  Global identification of MLL2-targeted loci reveals MLL2's role in diverse signaling pathways.

Authors:  Changcun Guo; Chun-Chi Chang; Matthew Wortham; Lee H Chen; Dawn N Kernagis; Xiaoxia Qin; Young-Wook Cho; Jen-Tsan Chi; Gerald A Grant; Roger E McLendon; Hai Yan; Kai Ge; Nickolas Papadopoulos; Darell D Bigner; Yiping He
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-08       Impact factor: 11.205

5.  Ca2+/S100 proteins act as upstream regulators of the chaperone-associated ubiquitin ligase CHIP (C terminus of Hsc70-interacting protein).

Authors:  Seiko Shimamoto; Yasuo Kubota; Fuminori Yamaguchi; Hiroshi Tokumitsu; Ryoji Kobayashi
Journal:  J Biol Chem       Date:  2013-01-23       Impact factor: 5.157

Review 6.  Functions of S100 proteins.

Authors:  R Donato; B R Cannon; G Sorci; F Riuzzi; K Hsu; D J Weber; C L Geczy
Journal:  Curr Mol Med       Date:  2013-01       Impact factor: 2.222

7.  Diagnostic significance of S100A2 and S100A6 levels in sera of patients with non-small cell lung cancer.

Authors:  Ting Wang; Yiqian Liang; Asmitananda Thakur; Shuo Zhang; Tian Yang; Tianjun Chen; Lei Gao; Mingwei Chen; Hui Ren
Journal:  Tumour Biol       Date:  2015-09-11

Review 8.  Joining S100 proteins and migration: for better or for worse, in sickness and in health.

Authors:  Stephane R Gross; Connie Goh Then Sin; Roger Barraclough; Philip S Rudland
Journal:  Cell Mol Life Sci       Date:  2013-06-30       Impact factor: 9.261

9.  S100 calcium binding proteins and ion channels.

Authors:  Anton Hermann; Rosario Donato; Thomas M Weiger; Walter J Chazin
Journal:  Front Pharmacol       Date:  2012-04-25       Impact factor: 5.810

Review 10.  The S100 Protein Family as Players and Therapeutic Targets in Pulmonary Diseases.

Authors:  Zeeshan Sattar; Alnardo Lora; Bakr Jundi; Christopher Railwah; Patrick Geraghty
Journal:  Pulm Med       Date:  2021-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.